Resistance to Third-Generation Cephalosporins and Other Antibiotics by Enterobacteriaceae in Western Nigeria

被引:7
|
作者
Okesola, A. O. [1 ]
Makanjuola, O. [1 ]
机构
[1] Univ Ibadan, Univ Coll Hosp, Coll Med, Dept Med Microbiol & Parasitol, Ibadan, Nigeria
关键词
Enterobacteriaceae; third-generation cephalosporins; resistance;
D O I
10.3844/ajidsp.2009.17.20
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Problem statement: The emergence and spread of resistance to third-generation cephalosporins are threatening to create species resistant to all currently available agents. The most common cause of bacterial resistance to beta-lactam antibiotics is the production of beta-lactamases and many of the 2nd and 3rd-generation penicillins and cephalosporins were specifically designed to resist the hydrolytic action of major beta-lactamases. However new beta-lactamases emerged against each of the new classes of beta-lactams that were introduced and caused resistance. This study was designed to determine the rate of resistance to 3rd-generation cephalosporins and other classes of antibiotics by the Enterobacteriaceae in this environment. Approach: One hundred bacteria isolates belonging to the family Enterobacteriaceae identified from different clinical specimens between October and December 2007 using standard bacteriological methods. These were subjected to antibiotic susceptibility testing to third-generation cephalosporins and other classes of antibiotics which included quinolones and an aminoglycoside using the Kirby-Bauer method of disc diffusion test. Results: Out of the total number of Enterobacteriaceae isolated in the study period, only 54.8% of the klebsiella species isolated were sensitive to ceftazidime, 48.4% to ceftriaxone and 30.7% to cefotaxime. With Escherichia coli however, the susceptibility pattern to the 3rd-generation cephalosporins was better (65.6% were sensitive to ceftazidime, 62.5% to ceftriaxone and 71.9% to cefotaxime). In proteus species, the susceptibility pattern was generally poor to the three classes of antibiotics(50% were sensitive to ceftazidime and ceftriaxone, 0% to cefotaxime, 33.3% to ciprofloxacin, 50% to gentamycin and 0% to amoxycillin/clavulanate). Conclusion/Recommendations: The poor susceptibility to amoxicillin/clavulanate demonstrated by all the isolates in this study showed the probability of new beta-lactamases production. Further studies therefore need to be done in this environment to determine the types of the beta-lactamases produced by the Enterobacteriaceae here, the prevalent rate of such isolates and the molecular analysis of the new beta-lactamases produced.
引用
收藏
页码:17 / 20
页数:4
相关论文
共 50 条
  • [21] Evolution of third generation cephalosporins resistance in Enterobacteriaceae from 2000 to 2008 in Perpignan hospital
    Mayoral, G.
    Ferreyra, M.
    Eden, A.
    Gueudet, P.
    Miquel, C.
    Lecaillon, E.
    PATHOLOGIE BIOLOGIE, 2010, 58 (01): : 7 - 10
  • [22] High prevalence of resistance to third-generation cephalosporins detected among clinical isolates from sentinel healthcare facilities in Lagos, Nigeria
    Chukwu, Emelda E.
    Awoderu, Oluwatoyin B.
    Enwuru, Christian A.
    Afocha, Ebelechukwu E.
    Lawal, Rahman G.
    Ahmed, Rahaman A.
    Olanrewaju, Ishola
    Onwuamah, Chika K.
    Audu, Rosemary A.
    Ogunsola, Folasade T.
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2022, 11 (01)
  • [23] High prevalence of resistance to third-generation cephalosporins detected among clinical isolates from sentinel healthcare facilities in Lagos, Nigeria
    Emelda E. Chukwu
    Oluwatoyin B. Awoderu
    Christian A. Enwuru
    Ebelechukwu E. Afocha
    Rahman G. Lawal
    Rahaman A. Ahmed
    Ishola Olanrewaju
    Chika K. Onwuamah
    Rosemary A. Audu
    Folasade T. Ogunsola
    Antimicrobial Resistance & Infection Control, 11
  • [24] Nephrotoxicity of Amoxicillin and Third-Generation Cephalosporins: An Updated Review
    Anne-Sophie Garnier
    Guillaume Drablier
    Marie Briet
    Jean-François Augusto
    Drug Safety, 2023, 46 : 715 - 724
  • [25] Salmonella meningitis: clinical experience of third-generation cephalosporins
    Huang, LT
    Ko, SF
    Lui, CC
    ACTA PAEDIATRICA, 1997, 86 (10) : 1056 - 1058
  • [26] Emergence of meningococci with reduced susceptibility to third-generation cephalosporins
    Deghmane, Ala-Eddine
    Hong, Eva
    Taha, Muhamed-Kheir
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (01) : 95 - 98
  • [27] Nephrotoxicity of Amoxicillin and Third-Generation Cephalosporins: An Updated Review
    Garnier, Anne-Sophie
    Drablier, Guillaume
    Briet, Marie
    Augusto, Jean-Francois
    DRUG SAFETY, 2023, 46 (08) : 715 - 724
  • [28] Third-generation cephalosporins for upper respiratory tract infections
    van Niekerk, CH
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2002, 92 (10): : 745 - 746
  • [29] Urinary Tract Infections Treated by Third-Generation Cephalosporins
    Bradley, John S.
    PEDIATRICS, 2022, 150 (01)
  • [30] Resistance to third-generation cephalosporins in Escherichia coli in the French community: The times they are a-changin'?
    Jeanvoine, Audrey
    Bouxom, Helene
    Leroy, Joel
    Gbaguidi-Haore, Houssein
    Bertrand, Xavier
    Slekovec, Celine
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (05)